CME Group, Weatherford International, RPM International And Other Big Stocks Moving Higher On Wednesday

Homozygous Familial Hypercholesterolemia (HoFH) - 7MM Market, Epidemiology, and Forecast - 2036 | RNAi and Targeted Therapies Expand Uptake and Investment Opportunities

The HoFH market is expected to expand through 2036, driven by improved genetic screening, earlier diagnosis, and adoption of targeted lipid-lowering therapies. With approximately 1,840 diagnosed prevalent cases in the 7MM in 2025, the market is shifting toward long-acting, receptor-independent therapies including RNA interference agents and ANGPTL3 inhibitors. Key unmet needs include limited treatment efficacy for patients with minimal LDL receptor function, delayed diagnosis, and high treatment burden.

Goldman Sachs Reinstates Neutral on Arrowhead Pharma, Announces $74 Price Target

Goldman Sachs analyst Andrea Newkirk reinstates Arrowhead Pharma (NASDAQ:ARWR) with a Neutral and announces $74 price target.

Nasdaq 100 Slips, 10-Year Yields Hit 19-Year Highs: Stock Market Today

Stocks slid as the 10-year Treasury yield hit a 19-year high on blowout PMI data; cybersecurity stocks bucked the selloff.

Arrowhead Achieves Clinical Validation for New Drug Platform

Arrowhead Pharmaceuticals reports interim Phase 1/2a data for ARO-DIMER-PA, demonstrating dual-gene silencing to treat high fat in blood.

Cango’s AI Pivot Gets First Customer

The company’s bitcoin mining business held steady in the second quarter, as its first high-performance computing center was ready to receive customers in July image credit: Bamboo Works Key

Shares of crypto-linked companies are trading higher amid a rise in Bitcoin after the CFTC submitted a proposal on Thursday to regulate crypto asset transactions and markets. This, along with yesterday's announcements from the CFTC and SEC, signals that regulatory agencies are taking action after the Clarity Act failed to advance in the Senate.